Assessment of left ventricular mass changes after arteriovenous fistula surgical banding in end-stage renal disease

Camilo Cortesi, Juan C. Duque, Sedki Mai, Laisel Martinez, Adriana Dejman, Roberto I Vazquez-Padron, Loay Salman, Marwan Tabbara

Research output: Contribution to journalArticle

Abstract

Left ventricular hypertrophy (LVH) is a multifactorial complication frequently seen in patients with advanced chronic kidney disease. An arteriovenous fistula (AVF) is the preferred method for hemodialysis access. Once functional, AVFs demonstrate better patency rates and fewer complications when compared to other forms of vascular access. AVFs have been implicated in cardiac remodeling, but it is controversial whether those changes can be reversed by surgical ligation or blood flow reduction. In this study, we describe a cohort of asymptomatic patients with LVH who underwent AVF banding with a two-dimensional-echocardiogram done before and after the intervention to evaluate the association between AVF surgical banding and left ventricular mass (LVM) changes. Our results show that AVF surgical banding did not alter the left ventricular mass index (LVMI) with a mean prebanding LVMI of 70.3 ± 57.5 g/m2 and mean postbanding LVMI of 81.9 ± 55.9 g/m2, (P = 0.4). Our study shows that AVF flow reduction by surgical banding did not alter LVMI, and therefore LVH, in end-stage renal disease patients who have not yet shown clinical manifestations of cardiac disease.

Original languageEnglish (US)
Pages (from-to)1280-1289
Number of pages10
JournalSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Volume29
Issue number6
DOIs
StatePublished - Nov 1 2018

Fingerprint

Arteriovenous Fistula
Chronic Kidney Failure
Left Ventricular Hypertrophy
Chronic Renal Insufficiency
Ligation
Blood Vessels
Renal Dialysis
Heart Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{de50fb647177406d88434e5fecfbc206,
title = "Assessment of left ventricular mass changes after arteriovenous fistula surgical banding in end-stage renal disease",
abstract = "Left ventricular hypertrophy (LVH) is a multifactorial complication frequently seen in patients with advanced chronic kidney disease. An arteriovenous fistula (AVF) is the preferred method for hemodialysis access. Once functional, AVFs demonstrate better patency rates and fewer complications when compared to other forms of vascular access. AVFs have been implicated in cardiac remodeling, but it is controversial whether those changes can be reversed by surgical ligation or blood flow reduction. In this study, we describe a cohort of asymptomatic patients with LVH who underwent AVF banding with a two-dimensional-echocardiogram done before and after the intervention to evaluate the association between AVF surgical banding and left ventricular mass (LVM) changes. Our results show that AVF surgical banding did not alter the left ventricular mass index (LVMI) with a mean prebanding LVMI of 70.3 ± 57.5 g/m2 and mean postbanding LVMI of 81.9 ± 55.9 g/m2, (P = 0.4). Our study shows that AVF flow reduction by surgical banding did not alter LVMI, and therefore LVH, in end-stage renal disease patients who have not yet shown clinical manifestations of cardiac disease.",
author = "Camilo Cortesi and Duque, {Juan C.} and Sedki Mai and Laisel Martinez and Adriana Dejman and Vazquez-Padron, {Roberto I} and Loay Salman and Marwan Tabbara",
year = "2018",
month = "11",
day = "1",
doi = "10.4103/1319-2442.248299",
language = "English (US)",
volume = "29",
pages = "1280--1289",
journal = "Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.",
issn = "1319-2442",
publisher = "Saudi Center for Organ Transplantation",
number = "6",

}

TY - JOUR

T1 - Assessment of left ventricular mass changes after arteriovenous fistula surgical banding in end-stage renal disease

AU - Cortesi, Camilo

AU - Duque, Juan C.

AU - Mai, Sedki

AU - Martinez, Laisel

AU - Dejman, Adriana

AU - Vazquez-Padron, Roberto I

AU - Salman, Loay

AU - Tabbara, Marwan

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Left ventricular hypertrophy (LVH) is a multifactorial complication frequently seen in patients with advanced chronic kidney disease. An arteriovenous fistula (AVF) is the preferred method for hemodialysis access. Once functional, AVFs demonstrate better patency rates and fewer complications when compared to other forms of vascular access. AVFs have been implicated in cardiac remodeling, but it is controversial whether those changes can be reversed by surgical ligation or blood flow reduction. In this study, we describe a cohort of asymptomatic patients with LVH who underwent AVF banding with a two-dimensional-echocardiogram done before and after the intervention to evaluate the association between AVF surgical banding and left ventricular mass (LVM) changes. Our results show that AVF surgical banding did not alter the left ventricular mass index (LVMI) with a mean prebanding LVMI of 70.3 ± 57.5 g/m2 and mean postbanding LVMI of 81.9 ± 55.9 g/m2, (P = 0.4). Our study shows that AVF flow reduction by surgical banding did not alter LVMI, and therefore LVH, in end-stage renal disease patients who have not yet shown clinical manifestations of cardiac disease.

AB - Left ventricular hypertrophy (LVH) is a multifactorial complication frequently seen in patients with advanced chronic kidney disease. An arteriovenous fistula (AVF) is the preferred method for hemodialysis access. Once functional, AVFs demonstrate better patency rates and fewer complications when compared to other forms of vascular access. AVFs have been implicated in cardiac remodeling, but it is controversial whether those changes can be reversed by surgical ligation or blood flow reduction. In this study, we describe a cohort of asymptomatic patients with LVH who underwent AVF banding with a two-dimensional-echocardiogram done before and after the intervention to evaluate the association between AVF surgical banding and left ventricular mass (LVM) changes. Our results show that AVF surgical banding did not alter the left ventricular mass index (LVMI) with a mean prebanding LVMI of 70.3 ± 57.5 g/m2 and mean postbanding LVMI of 81.9 ± 55.9 g/m2, (P = 0.4). Our study shows that AVF flow reduction by surgical banding did not alter LVMI, and therefore LVH, in end-stage renal disease patients who have not yet shown clinical manifestations of cardiac disease.

UR - http://www.scopus.com/inward/record.url?scp=85059231283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059231283&partnerID=8YFLogxK

U2 - 10.4103/1319-2442.248299

DO - 10.4103/1319-2442.248299

M3 - Article

C2 - 30588958

AN - SCOPUS:85059231283

VL - 29

SP - 1280

EP - 1289

JO - Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

JF - Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

SN - 1319-2442

IS - 6

ER -